Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has shared an announcement.
ResMed Inc has filed a notice regarding the proposed sale of securities under Rule 144, indicating that Michael J. Farrell, an officer and director, plans to sell 8,009 common shares valued at approximately $1,896,307.29. This sale, along with previous transactions, highlights insider trading activities but assures that no adverse, undisclosed information about the company’s operations has influenced these decisions.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc operates in the healthcare industry, specializing in sleep apnea and respiratory care solutions. The company provides a range of products such as continuous positive airway pressure (CPAP) devices and cloud-connected solutions aimed at improving patient outcomes and enhancing the quality of life for individuals with chronic respiratory conditions.
YTD Price Performance: 2.50%
Average Trading Volume: 960,170
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$55.5B
For an in-depth examination of RMD stock, go to TipRanks’ Stock Analysis page.
